APA način citiranja

Bhatia, S., Pavlick, A. C., Boasberg, P., Thompson, J. A., Mulligan, G., Pickard, M. D., . . . Hamid, O. (2016). A phase I study of the investigational NEDD8-activating enzyme inhibitor pevonedistat (TAK-924/MLN4924) in patients with metastatic melanoma. Invest New Drugs.

Čikaški stil citiranja

Bhatia, Shailender, Anna C. Pavlick, Peter Boasberg, John A. Thompson, George Mulligan, Michael D. Pickard, Hélène Faessel, Bruce J. Dezube, i Omid Hamid. "A Phase I Study of the Investigational NEDD8-activating Enzyme Inhibitor Pevonedistat (TAK-924/MLN4924) in Patients With Metastatic Melanoma." Invest New Drugs 2016.

MLA način citiranja

Bhatia, Shailender, et al. "A Phase I Study of the Investigational NEDD8-activating Enzyme Inhibitor Pevonedistat (TAK-924/MLN4924) in Patients With Metastatic Melanoma." Invest New Drugs 2016.